Research progress on antiviral therapy in hepatitis C-negative recipients receiving kidney transplantation from infected donors / 中华临床感染病杂志
Chinese Journal of Clinical Infectious Diseases
; (6): 395-400, 2022.
Article
en Zh
| WPRIM
| ID: wpr-993712
Biblioteca responsable:
WPRO
ABSTRACT
Kidney transplantation is the best option for end stage renal disease. Currently, shortage of donor kidneys become a global problem for kidney transplants, partly due to the abandonment of kidneys from donors infected with hepatitis C virus (HCV). With the advent of direct-acting antiviral drugs, the use of HCV infected donor kidneys has become an important measure to expand the donor pool. This article reviews the research progress on the safety, efficacy and timing of antiviral therapy for HCV-negative recipients receiving kidney transplantation from HCV-positive donors.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Clinical Infectious Diseases
Año:
2022
Tipo del documento:
Article